Cinnamon.
Research-backed compound with potential health benefits. Helps your body manage blood sugar levels. It may also have some mild antioxidant and anti-inflammatory effects.
Reviewed March 2026
- Category
- Compound
What Cinnamon is, and what it does.
- Does it work
- Maybe. Just don't expect it to replace diet, exercise, or actual medicine.
- How much to take
- 1-3 grams of Ceylon cinnamon daily. Start low. Don't mega-dose the Cassia type from the grocery store spice aisle.
- Time to feel it
- Within the first hour after a single 6 g dose taken with a meal.
- The first dose
- Nothing. It's a spice, not a drug. This is a long-term play that requires consistency.
- With regular use
- After 2-3 months, you might see a small improvement in fasting glucose or A1c numbers. It's subtle.
- How well tolerated
- Ceylon is well tolerated. Cassia is the one to watch. High doses of coumarin in Cassia can stress the liver. Save Cassia for your oatmeal, not for supplementation.
- How it feels
- Like nothing. The benefits are measured in lab tests, not feelings. Don't expect to feel different day-to-day.
- The overlooked benefit
- The starch-splitting enzymes it slows sit right at the gut wall, so it has more to do taken with a carb-heavy meal than on an empty stomach.
500 to 1,500mg a day is where Cinnamon works.
Source: J Med Food. 2011;14(9):884-889. Cinnamon for blood glucose control.
In a crossover trial, 30 adults aged 18 to 30, half with a BMI of 30 or more, ate 50 g of available carbohydrate as instant cereal plain or with 6 g of ground cinnamon. Blood glucose was lower with cinnamon at 15, 30, 45 and 60 minutes and the 120-minute glucose area under the curve was lower, while at 120 minutes blood glucose was higher with cinnamon than without. In a separate crossover trial in 14 healthy adults, 6 g of cinnamon with rice pudding lowered the postprandial glucose response and delayed gastric emptying, with no significant effect on satiety.
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Cinnamon is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- healthy glucose metabolismMeta-analysis
- steadier blood sugar after mealsRandomised trial
- triglycerides already in the normal rangeMeta-analysis
- antioxidant enzyme signallingIn vitro study
- a healthy inflammatory responseRandomised trial
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Chromium helps insulin bind and signal at its receptor as part of the chromodulin complex, and cinnamon's polyphenols make that same receptor signaling more responsive, so the pair supports the body's normal glucose metabolism through complementary steps of one insulin pathway.
Berberine switches on AMPK, the cellular energy sensor that prompts cells to take up glucose, while cinnamon works mainly through insulin-receptor signaling, so the two support normal glucose metabolism through separate and complementary routes.
Magnesium is a required cofactor for the enzymes that carry insulin's signal and for moving glucose into cells, and cinnamon supports the sensitivity of that signaling, so together they support the body's normal glucose metabolism from two different angles.
Cinnamon's proanthocyanidins and tannins bind ferric iron in the gut lumen and form complexes the enterocyte cannot take up. Taken in the same dose as an iron salt it lowers the fraction absorbed, so the two belong hours apart.
Ascorbate reduces ferric to ferrous iron and holds it soluble, which loosens the grip cinnamon polyphenols have on nonheme iron. Adding it to a polyphenol-heavy formula partly restores mineral uptake from the same meal.
Zinc is required for insulin to be stored as hexamers in the beta cell and for the enzymes that clear it, so zinc status shapes the hormonal side of glucose handling. Cinnamon acts on peripheral glucose uptake and hepatic output, a different point in the same loop.
Lipoic acid promotes GLUT4 movement to the cell surface and works as a mitochondrial cofactor, while cinnamon's polyphenols act largely on insulin receptor signalling and carbohydrate digestion. Combining them addresses two different steps of glucose disposal.
Gymnemic acids interfere with sweet taste and with intestinal glucose uptake, whereas cinnamon works after absorption. The two sit at opposite ends of the same postmeal curve.
Bitter melon supplies charantin and polypeptide-p, reported to act at the cell surface like insulin, while cinnamon polyphenols act on receptor phosphorylation. Formulas combine them because the routes are described as separate.
Corosolic acid from banaba is associated with increased cellular glucose transport, a mechanism independent of cinnamon's polyphenol signalling. They are stacked in glucose formulas for that reason.
Fenugreek's galactomannan raises the viscosity of gut contents so starch digestion products reach the blood more gradually. That blunts the peak cinnamon is then acting on, giving two mechanisms across one meal.
Inositol phosphoglycans act as second messengers after insulin binds its receptor, one step past where cinnamon's polyphenols act on receptor autophosphorylation. The pair covers signal initiation and signal relay.
Vanadium compounds inhibit protein tyrosine phosphatases, so receptor phosphorylation persists longer after insulin binds. That is a different lever from cinnamon's, which is why the two show up in the same trace-mineral glucose blends.
White mulberry leaf supplies 1-deoxynojirimycin, an alpha-glucosidase inhibitor that slows starch breakdown in the gut lumen. Cinnamon's polyphenols act later, at insulin signalling and glucose uptake in tissue. The two act at separate points, so a combined product touches both the delivery of glucose and its clearance. Post-meal glucose is a marker, not a health outcome.
Psyllium forms a viscous gel that slows gastric emptying and the diffusion of sugars to the intestinal wall. In one randomised trial, cinnamon lowered peak post-meal glucose while the study did not detect a change in insulin resistance indices, which is a failure to detect a difference rather than evidence that none exists. Combining a physical brake with a signalling effect is the usual formulation logic here. Both endpoints are markers measured over hours.
Glucomannan is a highly viscous konjac polysaccharide that slows nutrient transit. Cinnamon is generally added to such blends for its effect on post-meal glucose readings. The pairing itself has not been isolated in a dedicated human trial, so the basis is mechanistic rather than clinical.
Resistant starch escapes small-intestinal digestion and is fermented to short-chain fatty acids in the colon, which is a separate route to the second-meal glucose response. Cinnamon works on the immediate post-meal window. The two occupy different timescales rather than reinforcing the same step.
A 2024 clinical assessment paired l-carnitine with cinnamon and looked at weight and body-composition measures. Carnitine shuttles long-chain fatty acids into mitochondria; cinnamon's polyphenols act on glucose handling, so the rationale for pairing them is complementary rather than overlapping. Read the combination as tested once rather than settled.
Catechins and cinnamon proanthocyanidins are both polyphenols reported to move glucose and lipid markers modestly. Their effects on the same panel are more likely additive than multiplicative. No combination trial defines the joint size of the effect.
Cinnamon supplementation has been examined for its effect on NF-kB and SIRT1 expression, which are regulatory markers rather than clinical endpoints. Curcuminoids are studied against a similar marker set. The pairing is conventional in botanical blends and its combined magnitude has not been measured.
Quercetin and cinnamon's proanthocyanidins both participate in redox cycling and can regenerate one another's oxidised forms in vitro. That chemistry is well described in solution; whether it changes anything measurable after a capsule is swallowed is not established. Count it as mechanistic.
Piperine slows intestinal and hepatic conjugation of several polyphenols, raising their plasma exposure. Cinnamon's cinnamaldehyde and procyanidins are conjugated by the same enzyme families, so the pairing is plausible. Nobody has measured cinnamon exposure with and without piperine in people, so the size is unknown.
Activated charcoal binds a wide range of small organic molecules in the gut lumen, including plant polyphenols and aldehydes. Taken in the same window as cinnamon it reduces how much reaches the circulation. Separating the two by several hours is the usual formulation answer.
Cassia bark contains coumarin, and the name alone drives a widespread assumption of an anticoagulant interaction. Plain coumarin is not the 4-hydroxycoumarin structure that acts on vitamin K recycling, so the assumption does not follow from the chemistry. With a fibrinolytic ingredient like nattokinase, the honest position is that no mechanism is established and no combination has been studied.
Nothing specific on file for Cinnamon. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Cinnamon actually does.
Cinnamon bark's dominant aroma compound is cinnamaldehyde, and its main water-soluble polyphenols are a family of A-type procyanidins.
Cassia-type cinnamon carries far more coumarin than Ceylon-type bark, which is why the two get listed separately on labels and why several national authorities cap daily intake of cassia powder.
Polyphenol-rich bark powders bind plant-source iron and other minerals inside your gut, the same tannin chemistry you see with tea and coffee.
In whole ground bark the polyphenols sit inside plant cell-wall material, so gram for gram a water or alcohol extract gives you a different mix of compounds than the powder it came from.
Where Cinnamon comes from.
It is tree bark, peeled and dried until it curls into sticks, then either ground or extracted with water or alcohol. The two common types, cassia and Ceylon, come from different trees and differ in a compound called coumarin, so the species on the label is worth reading.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
Cinnamomum cassia is grown mainly in southern China, Vietnam and Indonesia; C. zeylanicum in Sri Lanka and southern India. Trees are cut back so that thin shoots regrow and can be peeled.
The inner bark is separated from the outer layer and left to dry, during which it curls into the quills sold as sticks. Ceylon quills are made of many thin layers rolled together; cassia is a single thicker curl.
Dried quills are ground to powder for capsules and culinary use. No chemistry is applied at this step; the constituent profile is the bark's own.
Ground bark is extracted with hot water for the polar procyanidin fraction, or with ethanol or hydroethanolic mixtures for a broader profile, then filtered.
The extract is concentrated under vacuum and spray-dried, usually onto a carrier such as maltodextrin, which is why extract labels state a carrier.
Extract lots are assayed against a declared marker, commonly total polyphenols or type-A procyanidins, and cassia-sourced material is additionally tested for coumarin.
Getting Cinnamon from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across trials in adults with elevated blood sugar, cinnamon lowered fasting blood glucose by about 15 mg/dL and HbA1c by about 0.56 percentage points, with very large variation between the studies.Meta-analysis. de Moura et al., 2025 (Nutrition Reviews). PMID 38917435 ↗
- Pooling 9 trials in 641 adults, cinnamon lowered systolic blood pressure by about 5 mmHg and diastolic blood pressure by about 3 mmHg, mainly at doses of 2 g a day or less taken for longer than 8 weeks.Meta-analysis. Hadi et al., 2020 (Clinical Nutrition ESPEN). PMID 32220351 ↗
- Across 12 trials in 786 adults, cinnamon was associated with about 1 kg lower body weight and a waist circumference about 2.4 cm smaller than control.Meta-analysis. Mousavi et al., 2019 (Clinical Nutrition). PMID 30799194 ↗
- Across trials in adults, cinnamon showed no detectable overall change in the liver enzymes ALT, AST and ALP, with a reduction in ALT seen only in some subgroups.Meta-analysis. Shekarchizadeh-Esfahani et al., 2021 (Complementary Therapies in Medicine). PMID 33639251 ↗
- Pooling trials in adults, cinnamon supplementation improved several cardiovascular risk measures, with the certainty of the evidence rated low to moderate.Meta-analysis. Jafari et al., 2025 (Journal of Health, Population and Nutrition). PMID 40611215 ↗
- Across trials in adults, cinnamon supplementation was associated with lower blood pressure and changes in oxidative stress and inflammatory biomarkers.Systematic review. Zhang et al., 2024 (Nutrition, Metabolism and Cardiovascular Diseases). PMID 39299867 ↗
- An updated pooling of trials in adults with elevated blood sugar found cinnamon supplementation improved blood sugar control measures.Meta-analysis. Moridpour et al., 2024 (Phytotherapy Research). PMID 37818728 ↗
- Pooling randomised trials, cinnamon supplementation was associated with small changes in circulating liver enzyme levels.Meta-analysis. Mousavi et al., 2021 (Phytotherapy Research). PMID 34212447 ↗
- In adults with clustered metabolic risk factors, pooled trials showed cinnamon supplementation improved blood lipid measures.Meta-analysis. Wu et al., 2022 (Complementary Therapies in Clinical Practice). PMID 35803022 ↗
- Pooled randomised data reported improvements in fasting glucose and several lipid measures with cinnamon supplementation.Meta-analysis. Zhou et al., 2022 (Frontiers in Physiology). PMID 36505061 ↗
- The pooled analysis reported a small reduction in blood pressure readings with cinnamon supplementation, with the effect concentrated in younger participants.Systematic review. Ghavami et al., 2021 (Endocrine, Metabolic and Immune Disorders Drug Targets). PMID 32727334 ↗
- Pooled randomised trials reported reductions in triglycerides and total cholesterol, with less consistent movement in HDL.Meta-analysis. Fateh et al., 2024 (Clinical Nutrition Research). PMID 38362130 ↗
- Cassia cinnamon lowered peak blood glucose after a challenge, but the study did not detect improvement in insulin resistance indices.Randomised trial. Gutierrez et al., 2016 (Journal of Dietary Supplements). PMID 26716656 ↗
- Ceylon cinnamon extract was assessed for lipid and glucose measures alongside tolerability monitoring in adults.Randomised trial. Muthukuda et al., 2025 (PLoS One). PMID 39854533 ↗
- Cinnamon supplementation changed expression of NF-kB and SIRT1, which are regulatory markers rather than clinical endpoints.Randomised trial. Davari et al., 2020 (Nutrition Journal). PMID 31901246 ↗
- Berberine combined with cinnamon was assessed for glycaemic and lipid markers and for tolerability against a comparator.Randomised trial. Mansour et al., 2025 (European Journal of Nutrition). PMID 39998703 ↗
- The trial reported reductions in anthropometric measurements such as waist circumference over the supplementation period.Randomised trial. Lira Neto et al., 2025 (Revista Brasileira de Enfermagem). PMID 40667904 ↗
- Cinnamon added to a Tabata training programme was associated with changes in metabolic markers and body composition beyond training alone.Randomised trial. Sabzevari Rad et al., 2025 (Journal of the International Society of Sports Nutrition). PMID 40970779 ↗
- Cinnamon supplementation was associated with changes in self-reported eating-behaviour scores, which are questionnaire measures.Randomised trial. Gholami et al., 2024 (BMC Nutrition). PMID 39113092 ↗
- L-carnitine with cinnamon was assessed for weight and body-composition change over the study period.Randomised trial. Fadheel et al., 2024 (Wiadomosci Lekarskie). PMID 38691789 ↗
- Dietary cinnamon altered performance, egg quality and immune measures in laying hens.Animal study. Dosoky et al., 2021 (Poultry Science). PMID 34710709 ↗
These are the studies our verdict leans on, chosen from the 56 we read for Cinnamon. The full linked list is below.
The studies, linked.
9 sources behind our Cinnamon verdict: peer-reviewed studies and registered clinical trials. Every one links straight to PubMed, the journal, or ClinicalTrials.gov. Read them yourself.
- Clinical trialCinnamon Trial-Assessment of the effeCt of lIfestyle iNtervention Plus Water-soluble ciNnAMon Extract On loweriNg Blood Glucose in Pre-diabetics: A Randomized, Double-blind, Multicenter, Placebo Controlled TRIAL.ClinicalTrials.gov ↗NA · 229 participants · Completed
- Clinical trialThe Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: a Randomized Controlled Trial.ClinicalTrials.gov ↗NA · 120 participants · Completed
- Clinical trialEffects of Cinnamon Spice on Glucose, Insulin, GI Hormone and Microbiome in Obese Individuals With Pre-DiabetesClinicalTrials.gov ↗NA · 20 participants · Completed
- Clinical trialA Randomized, Controlled, Double-blind, Cross-over Clinical Trial, Evaluating the Effect of MealShape™ on the Postprandial Glycemia After Eating Standard Food, in Healthy Volunteers.ClinicalTrials.gov ↗NA · 18 participants · Completed
- Clinical trialEffects of Cinnamon on Postprandial Blood Glucose, and Insulin in Subjects With Type 2 Diabetes or Impaired Glucose ToleranceClinicalTrials.gov ↗10 participants · Completed
- Clinical trialEffect of Cinnamon on Gastric Emptying, Arterial Stiffness, Postprandial Lipaemia, Glycaemia, and Appetite Responses to High-fat BreakfastClinicalTrials.gov ↗NA · 9 participants · Completed
- Clinical trialThe Effects of Ceylon Cinnamon (Cinnamomum Verum) Supplementation on Blood Glucose, Lipid Profile Levels, Body Mass Index, and Pain Intensity Among Adult Individuals With Painful Diabetic Peripheral Neuropathy: A Double-Blind Randomized Controlled TrialClinicalTrials.gov ↗NA · 164 participants · Recruiting
- Clinical trialComparative Effectiveness of Ginger-Mint and Cinnamon-Flavored Gum in Preventing Nausea and Vomiting Following Pressurized Intraperitoneal Aerosol ChemotherapyClinicalTrials.gov ↗NA · 75 participants · Not yet recruiting
- Clinical trialImproving Insulin Resistance in Gynecological Cancer Patients Post Treatment Using Integrative and Functional Food Plan With or Without Cinnamon SupplementationClinicalTrials.gov ↗NA · Withdrawn
Evidence surfaced via Semantic Scholar (Allen Institute for AI) and ClinicalTrials.gov. Ranked by study type and citation weight, not cherry-picked.
Problems people have reported.
Read this carefully. These are 22,388 voluntary, unverified reactions reported to the FDA (openFDA). The number mostly reflects how popular Cinnamon is, not how risky it is. A report is not proof Cinnamon caused anything. It is a signal of what to watch for, nothing more.
Source: openFDA adverse-event reports. Voluntary reporting, not an incidence rate.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.


